Compound Summary
Compound Name: | 			Xylometazoline hydrochloride | 
Compound CID: | 			5282386 | 
Synonyms: | 			Xylometazoline hydrochloride 1218-35-5 Xylometazoline HCl Xylometazoline (hydrochloride) 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride More... | 
Iupac Name: | 			2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride | 
InChI: | 					InChI=1S/C16H24N2.ClH/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15;/h8-9H,6-7,10H2,1-5H3,(H,17,18);1H | 
InChIKey: | 				YGWFCQYETHJKNX-UHFFFAOYSA-N | 
Canonical Smiles: | 		CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl | 
Isomeric Smiles: | 			CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl | 
Molecular Weight: | 		280.83 | 
Molecular Formula: | 			C16H25ClN2 | 
Molecular Weight: | 		280.83 | 
Molecular Formula: | 			C16H25ClN2 | 
Hydrogen Bond Donor Count: | 			2 | 
Hydrogen Bond Acceptor Count: | 			1 | 
Rotatable Bond Count: | 			3 | 
Heavy Atom Count: | 					19 | 
Complexity: | 				302 | 
| Xylometazoline hydrochloride | Xylometazoline hydrochloride | 
|---|---|
Xylometazoline hydrochloride | 			
1218-35-5 | 
Xylometazoline HCl | 			
Xylometazoline (hydrochloride) | 
2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride | 			
MFCD00238707 | 
MLS000069695 | 			
UNII-X5S84033NZ | 
1H-Imidazole, 2-4-(1,1-dimethylethyl)-2,6-dimethylphenylmethyl-4,5-dihydro-, hydrochloride (1:1) | 			
SMR000058526 | 
DSSTox_CID_25223 | 			
DSSTox_RID_80760 | 
DSSTox_GSID_45223 | 			
2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride | 
2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride | 			
X5S84033NZ | 
Xylometazoline hydrochloride (USP) | 			
2-(4-tert-butyl-2,6-dimethylphenyl)methyl-4,5-dihydro-1H-imidazole;hydrochloride | 
SR-01000000230 | 			
NCGC00016101-02 | 
CAS-1218-35-5 | 			
Prestwick_574 | 
Opera_ID_1744 | 			
Neo-Synephrine II (TN) | 
SCHEMBL41837 | 			
MLS001076518 | 
SPECTRUM1500614 | 			
CHEMBL1256400 | 
DTXSID3045223 | 			
REGID_for_CID_5282386 | 
HMS1568N07 | 			
HMS1921K09 | 
Pharmakon1600-01500614 | 			
Xylometazoline Hydrochloride ,(S) | 
BCP22148 | 			
HY-B0475 | 
Tox21_110305 | 			
Tox21_501269 | 
CCG-39900 | 			
NSC757378 | 
s2576 | 			
AKOS015895456 | 
Tox21_110305_1 | 			
AC-8301 | 
KS-5144 | 			
LP01269 | 
NSC-757378 | 			
NCGC00016101-10 | 
NCGC00094506-01 | 			
NCGC00094506-02 | 
NCGC00094506-03 | 			
NCGC00094506-04 | 
NCGC00094506-05 | 			
NCGC00261954-01 | 
H812 | 			
AB0013278 | 
EU-0101269 | 			
FT-0603554 | 
SW196748-3 | 			
D00757 | 
X 6000 | 			
Xylometazoline hydrochloride, analytical standard | 
218X355 | 			
A804796 | 
J-004686 | 			
SR-01000000230-2 | 
SR-01000000230-7 | 			
Q27293585 | 
Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard | 			
Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard | 
Xylometazoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material | 			
Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard | 
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 7.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 7.000000000000000 | 1 | 1 |